{"id":"W2752063004","doi":"10.1136/annrheumdis-2001.1216","title":"OP0086 The fully human anti-tnf monoclonal antibody, adalimumab (d2e7), dose ranging study: the 24-week clinical results in patients with active ra on methotrexate therapy (the armada trial)","year":2001,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sinai Health System","funders":"","keywords":"Adalimumab; Medicine; Rheumatoid arthritis; Methotrexate; Placebo; Internal medicine; Adverse effect; Dose-ranging study; Refractory (planetary science); Gastroenterology; Surgery; Double blind; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003623085,0.0004284593,0.0009403506,0.0001447362,0.0005755192,0.00009833475,0.001344582,0.00008542032,0.00007196514],"category_scores_gemma":[0.002377716,0.0001616041,0.0005132326,0.0008760312,0.000851407,0.0001584328,0.0003193917,0.0006561293,0.00001950185],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004410713,"about_ca_system_score_gemma":0.001909129,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001206224,"about_ca_topic_score_gemma":0.00007977342,"domain_scores_codex":[0.9928056,0.002662281,0.001332208,0.0005694709,0.001926776,0.0007036728],"domain_scores_gemma":[0.9918329,0.004713615,0.0007897676,0.00210613,0.0003601812,0.0001974712],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5817444,0.03684432,0.07337539,0.0002532601,0.007512697,0.0002331897,0.01366358,0.002328053,0.00002587226,0.0002364911,0.009671559,0.2741112],"study_design_scores_gemma":[0.2005028,0.004688419,0.7878844,0.001012687,0.0003802949,0.0000102672,0.002930174,0.001319601,0.0001184201,0.0004189965,0.0004569086,0.0002770384],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9868256,0.0005312665,0.000003959943,0.00652011,0.0002343422,0.005438127,0.00006715641,0.00003480917,0.0003446124],"genre_scores_gemma":[0.9970849,0.001050827,0.000009870266,0.001166286,0.0001434082,0.0001695989,0.00003905568,0.00005900984,0.0002770263],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.714509,"threshold_uncertainty_score":0.6590022,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1407855603457767,"score_gpt":0.4322839467827096,"score_spread":0.2914983864369329,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}